Diabetic Foot Ulcers and Pressure Ulcers Market to Reach US$4.9 Billion by 2024; Immobility in Patients due to Chronic Ailments to Fuel Demand for Treatments, Says TMR - Seite 2

Talking about chronic ailments, diabetes is one of the leading causes of diabetic foot ulcers and pressure ulcers. Diabetes has remained one of the most prevalent chronic conditions affecting millions around the world. "As changing lifestyle and unhealthy lifestyle have bolstered the prevalence of diabetes, subsequently the incidence of diabetic foot ulcers and pressure ulcers is increased as well," said a lead TMR analyst.

Also the market is tremendously gaining from favorable demographic and the rising aging population who are more prone to developing chronic ailments. There is a strong co-relation between age and severe chronic ailments, risk of diabetes, obesity, and other illnesses. As chronic ailments may restrict mobility, aging population faces increased risk of foot ulcers and pressure ulcers. As people become more aware of these conditions, the demand for supporting treatment and medications for diabetic foot ulcers and pressure ulcers will increase. This will give the market significant impetus.

Fill the form for an exclusive sample of this report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21803

Cost Burden of Diabetic Foot Ulcer Treatment Could Hamper Growth 

On the flip side, the cost burden of diabetic foot ulcers and pressure ulcers treatments is inhibiting the market's trajectory to an extent. Lack of preventive measure taken by healthcare providers and patients has been a major reason behind the widespread incidence of diabetic foot ulcers and pressure ulcers. This creates additional cost burden, as the expenditure incurred on the illness is often quite high. The rising incidence of diabetic foot ulcers has therefore compelled healthcare providers and patients' families to focus on preventive measures, to save any additional expenditure and discomfort on the part of patients. This could have a negative impact on the market.

Nevertheless, biologics are increasingly used for the treatment of diabetic foot ulcers and pressure ulcers. This is a relatively novel method and holds promise for market's growth in the near future.

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/diabetic-foot-ulcers-pressure-ulcers-market.htm

This review is based on a TMR report, titled "Diabetic Foot Ulcers and Pressure Ulcers Market (Type of Wound - Diabetic Foot Ulcers (Grade 0, Grade 1, Grade 2, Grade 3, Grade 4, and Grade 5) and Pressure Ulcers (Stage 1, Stage 2, Stage 3, and Stage 4); Treatment Type - Wound Care Dressings (Surgical Debridement, Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, and Hydrogel Dressings), Bio-actives (Skin Grafts & Skin Substitutes and Growth Factors), and Wound Care Devices (Negative Pressure Wound Therapy and Ultrasound Therapy); End Users - Hospital Inpatient Settings, Hospital Outpatient Settings, Community Health Centers, and Home Healthcare) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024."